搜索筛选:
搜索耗时1.4561秒,为你在为你在102,285,761篇论文里面共找到 44 篇相符的论文内容
类      型:
[会议论文] 作者:Ning Shao,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Ning Shao,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Hua Xu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:jian ma,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
Objective Prostate cancer accounts for 19%of estimated new cancer cases in men and is the third primary cause of male cancer-related mortality after lung cancer and colon cancer in United States....
[会议论文] 作者:Hua Xu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
Objective Androgen deprivation therapy(ADT)with antiandrogens targeting androgens/androgen receptor(AR)signaling is the standard used to treat prostate cancer in different clinical settings besides su...
[期刊论文] 作者:Dingwei Ye,Wei Zhang,Lulin Ma,, 来源:中国癌症研究:英文版 年份:2019
Objective: Potential of combined androgen blockade(CAB) has not been explored extensively in Chinese males with prostate cancer(PCa). Therefore, this study eval...
[期刊论文] 作者:Chengyuan Gu,Yao Zhu,Dingwei Ye,, 来源:The Chinese-German Journal of Clinical Oncology 年份:2013
Telomere maintenance genes play an important role in maintaining the integrity of the telomere structure that protects chromosome ends,and telomere dysfunction...
[会议论文] 作者:Yu Wei,Yao Zhu,DingWei Ye, 来源:2019中国肿瘤学大会 年份:2019
Objective Prostate cancer is a worldwide most occurred malignancy in male population....
[会议论文] 作者:Jun Wang,Yao Zhu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Jun Wang,Yao Zhu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:wenjun xiao,Yao Zhu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
Objective Neuroblastoma(NB)is the most common extracranial solid tumor in children,with approximately 650 cases per year in the United States.Over half of children with neuroblastoma present with meta...
[会议论文] 作者:Beihe Wang,Yao Zhu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Junlong Wu,Yao Zhu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Yue Wang,Bo Dai,DingWei Ye, 来源:亚洲男性学杂志(英文版) 年份:2017
Androgen deprivation therapy (ADT) is the standard of care for patients with metastatic prostate cancer. However, whether serum testosterone levels, using a cut?off point of 50 ng dl?1, are related to the effective time of ADT in newly diag......
[会议论文] 作者:Junlong Wu,Chengyuan Gu,Shengming Jin,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:SHENGMING JIN,JUNLONG WU,WEIJIE GU,DINGWEI YE, 来源:2019中国肿瘤学大会 年份:2019
Objective Currently,obvious survival differences exist between the subgroups of stage Ⅲ RCC patients.Therefore,better signatures are required to help predict prognosis for stage Ⅲ RCC patients....
[会议论文] 作者:jian ma,Dingwei Ye,Yuqian Yan,Haojie Huang, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Jiaming Wei,Shengming Jin,Junlong Wu,Dingwei Ye, 来源:2019中国肿瘤学大会 年份:2019
Objective In this study,we used population-based data from the Surveillance,Epidemiology and End Results(SEER)database to explore the prognostic value and identify optimal candidates of PTS for semino...
[会议论文] 作者:SHENGMING JIN,JUNLONG WU,WEIJIE GU,DINGWEI YE, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Yao Zhu,HongKai Wang,YuanYuan Qu,DingWei Ye, 来源:亚洲男性学杂志(英文版) 年份:2015
Prostate cancer is now becoming an emerging health priority in East Asia. Most of our current knowledge on Prostate cancer has been generated from studies conducted in Western population; however, there is considerable heterogeneity of Pros......
相关搜索: